NEW YORK, March 13, 2017 (GLOBE NEWSWIRE) -- Chicago-based R1 RCM Inc. (OTC Pink:ACHI) (“R1” or the “Company”), a leading provider of revenue cycle management and physician advisory services to healthcare providers, announced today that it has received approval to list on the Nasdaq Capital Market effective at the opening of trading on Wednesday, March 15, 2017. Joe Flanagan, R1’s President and CEO, will ring the opening bell in honor of the occasion. The Company’s new stock symbol will be RCM (NASDAQ:RCM).
“Listing on Nasdaq is a key milestone for R1 and reflects the progress we continue to make as we embark on our next phase of growth,” said Flanagan, “We are thrilled to be listed on one of the most dynamic markets in the world and look forward to the opportunities this listing will provide.”
About R1 RCM
R1 serves as the one revenue cycle management partner for select hospitals and healthcare systems regardless of their payment models, partner engagement strategies, or settings of care. The company uses a proven operating model based on the R1 Performance Stack℠ designed to fit seamlessly into any healthcare organization’s infrastructure and to enhance the patient experience, improve provider economics, and provide revenue predictability. To learn more visit: r1rcm.com.
R1 RCM Inc.